Health knowledge made personal
WellPage for Lovenox Administration
+ Bookmark › Share
Go
Search posts:

Lovenox Administration - Articles

FDA Drug Safety Communication: Updated recommendations to decrease risk of spinal column bleeding and paralysis in patients on l by FDA Posted Wed 06 Nov 2013 11:53am View and print full Drug Safety Communication  (PDF - 88KB) Safety Announcement [11-6-2013] The U.S. Food and Drug Administration (FDA) is recommending that health care professionals carefully consider the timing of spinal catheter placement and removal in patients taking anticoagulant drugs, ... Read on »
Generic Lovenox Approved for Deep Vein Thrombosis by HealthFinder Posted Fri 23 Jul 2010 10:00am healthnewslink A condition that could cause deadly blood clots FRIDAY, July 23 (HealthDay News) -- ... Read on »
Ethics of Branded vs. Generic Drugs by Linda MacDonald Glenn Healthy Living ProfessionalHealth Maven Posted Sun 24 Aug 2008 3:59pm On May 15, 2008, an article in the Wall Street Journal reported that a United States appeals court upheld a lower-court ruling striking down patents for Lovenox, an anticoagulant manufactured by Sanofi-Aventis. This may clear the way for generic competition. When a pharmaceutical company discovers or develops a promising new compound, they ... Read on »
FDA Approves First Generic Injection Drug to Prevent Deep Vein Thrombosis by Medical Quack Patient ExpertHealth Maven Posted Sat 24 Jul 2010 10:36pm This is good news in the cost department.  As stated below the name brand drug is made from heparin so I am guessing the same active ingredient is present here.  If a blood clot is detected then there are stents that can be put in place in the legs and you can read more at the link below on how this works.  BD The U.S. Food and Drug ... Read on »
Back in the Saddle by PM, RN Registered Nurse Posted Tue 27 Jan 2009 7:13pm Our clinical focus for our first week back in med/surg was "Leaders and Management". Some questions posed to us in our weekly topic related to the differences between leadership and management, the interdependence of leaders and followers, and the unsuitability of new graduates for management positions. Personally, my goal was to get through ... Read on »
Low Molecular Weight Heparins: Drug Safety Communication - Recommendations to Decrease Risk of Spinal Column Bleeding and Paraly by FDA Posted Wed 06 Nov 2013 1:50pm [Posted 11/06/2013] AUDIENCE: Pharmacy, Cardiology, Anesthesiology ISSUE: The U.S. Food and Drug Administration (FDA) is recommending that health care professionals carefully consider the timing of spinal catheter placement and removal in patients taking anticoagulant drugs, such as enoxaparin, and de ... Read on »
Health Headlines - August 29 by Meredy Registered NurseHealth Maven Posted Thu 23 Oct 2008 2:21pm Almost 1,000 People Died From Katrina: Study Some 986 deaths in Louisiana were caused directly or indirectly by Hurricane Katrina, making it the deadliest hurricane to hit the U.S. Gulf Coast in 80 years, new research timed to the storm's third anniversary finds. Study authors were from the Louisiana Department of Health and Hospitals, an ... Read on »
FDA Collaboration From a Drug Company Leads to Legal Suit and Questions of Compromised Integrity-Tainted Heparin by Medical Quack Patient ExpertHealth Maven Posted Sun 14 Nov 2010 11:01am Amphastar Pharmaceuticals filed a lawsuit against the FDA in this area that goes back to the block on imports of heparin, and thus was not able to bring a generic equivalent to market.  Momenta Pharmaceuticals donated time and effort to help the FDA and thus won first approval.  We all remember the tainted heparin issues on the compound coming ... Read on »
FDA Approves First Generic Enoxaparin Sodium Injection by Medline Plus Posted Fri 23 Jul 2010 4:27pm FDA Approves First Generic Enoxaparin Sodium Injection The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used for multiple indications including prevention of deep vein thrombosis (DVT), a potentially deadly blood clotting condit ... Read on »
Administrative Procedures for CLIA Categorization - Guidance for Industry and Food and Drug Administration Staff by Health & Human Services Posted Wed 12 Mar 2014 12:00am On February 28, 1992, the Department of Health and Human Services (DHHS) published laboratory standards regulations (57 FR 7002) implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. 263a). The implementing regulations... Read on »